Neonatal drug therapy: The first frontier of therapeutics for children
about
Neonatal pain management: still in search for the Holy GrailNeonatal abstinence syndrome: Pharmacologic strategies for the mother and infant.Relation between safe use of medicines and Clinical Pharmacy Services at Pediatric Intensive Care Units.Pharmacometric Approaches to Personalize Use of Primarily Renally Eliminated Antibiotics in Preterm and Term Neonates.Design and conduct of early phase drug studies in children: challenges and opportunitiesClinical pharmacology of analgosedatives in neonates: ways to improve their safe and effective use.Impact of Drug Treatment at Neonatal Ages on Variability of Drug Metabolism and Drug-drug Interactions in Adult Life.Adverse drug events in pediatric intensive care are common, but improvement strategies exist and are effective.A Mechanism to Explain Ototoxicity in Neonates Exposed to Bumetamide: Lessons to Help Improve Future Product Development in Neonates.Juvenile Nonclinical Safety Studies in Support of Pediatric Drug Development.Simvastatin prevents and reverses chronic pulmonary hypertension in newborn rats via pleiotropic inhibition of RhoA signaling.Quantitative analysis of gentamicin exposure in neonates and infants calls into question its current dosing recommendations.Human retinal endothelial cells and astrocytes cultured on 3-D scaffolds for ocular drug discovery and development.Substitution as a Strategy to Improve Excipient Exposure in Neonates: One Piece of the Puzzle.Rational Use of Medicines in Neonates: Current Observations, Areas for Research and Perspectives
P2860
Q28078751-7F25BA5E-052F-4917-9F73-4B87033E42AAQ36730570-23690A6A-5068-4DE6-9A61-AAA5E8966F27Q37524249-46E94F43-2E7D-453E-948E-3689ABAAC17FQ38696468-BCE3DD6C-4FF2-4C10-9721-66A9EBE5DDE7Q38879907-E56B319B-1DAC-4166-A05A-4485B2AF44CCQ38882590-E5E1D7AC-0EC6-4993-8290-5526FCB8F6E2Q39201730-50F048AB-6694-460F-B0D9-BAF4396E3849Q39636349-22CF7F98-E18E-4E0E-B51C-B9A40D7E7DBDQ44982480-3CD1814B-7E5A-4B2F-98D8-DF9A888DD8B8Q46330140-43801FEC-5F47-443B-BD64-1CAFCE83C423Q48490217-71BC8834-ED18-47B3-8033-B40A26D84560Q48514081-CA696810-6ED7-44CF-9839-ADC6DC7AEEA1Q50040024-ACFD1D2A-C2E9-4F0C-A468-9AD86F485A6AQ50856147-D3EACEBF-7546-4992-8AF3-228BD3FF0A62Q58738472-55048D36-96EB-43EB-A0CA-3A90FF16FE70
P2860
Neonatal drug therapy: The first frontier of therapeutics for children
description
2015 nî lūn-bûn
@nan
2015 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Neonatal drug therapy: The first frontier of therapeutics for children
@ast
Neonatal drug therapy: The first frontier of therapeutics for children
@en
Neonatal drug therapy: The first frontier of therapeutics for children
@nl
type
label
Neonatal drug therapy: The first frontier of therapeutics for children
@ast
Neonatal drug therapy: The first frontier of therapeutics for children
@en
Neonatal drug therapy: The first frontier of therapeutics for children
@nl
prefLabel
Neonatal drug therapy: The first frontier of therapeutics for children
@ast
Neonatal drug therapy: The first frontier of therapeutics for children
@en
Neonatal drug therapy: The first frontier of therapeutics for children
@nl
P2860
P3181
P356
P1476
Neonatal drug therapy: The first frontier of therapeutics for children
@en
P2093
J van den Anker
P2860
P304
P3181
P356
10.1002/CPT.166
P407
P577
2015-07-22T00:00:00Z